S-005151
- Generic Name
- S-005151
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Shionogi
- Target Recruit Count
- 627
- Registration Number
- NCT05953480
- Locations
- 🇺🇸
Munson Healthcare, Traverse City, Michigan, United States
🇺🇸Mayo Clinic Hospital-Rochester, St. Marys Campus - PPDS, Rochester, Minnesota, United States
🇺🇸Nuvance Health Medical Practice, PC- Neurosurgery, Great Neck, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath